Cost Effectiveness and Resource Allocation

Papers
(The TQCC of Cost Effectiveness and Resource Allocation is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
The use of cost-effectiveness analysis for health benefit package design – should countries follow a sectoral, incremental or hybrid approach?68
Third-line multiple myeloma treatment of inpatients in a German cancer center: analysis of potential cost savings due to decreased renal insufficiency54
Comparison of current relative value unit-based prices and utility between common surgical procedures, including orthopedic surgeries, in South Korea36
A cost-effectiveness analysis of the combination of serplulimab with chemotherapy for advanced esophageal squamous cell carcinoma: insights from the ASTRUM-007 trial32
Cost-effectiveness of implant movement analysis in aseptic loosening after hip replacement: a health-economic model30
Systematic review of the evidence sources applied to cost-effectiveness analyses for older women with primary breast cancer29
Developing and validating a multi-criteria decision analytic tool to assess the value of cancer clinical trials: evaluating cancer clinical trial value28
Comparative effectiveness and cost evaluation of Risankizumab and Adalimumab in the management of psoriasis: a real-world study in Saudi Arabia24
Cost-effectiveness of sacituzumab govitecan versus single-agent chemotherapy for metastatic triple-negative breast cancer: a trial-based analysis23
Optimal strategies to screen health care workers for COVID-19 in the US: a cost-effectiveness analysis22
Costs and cost-effectiveness of HIV counselling and testing modalities in Southern Mozambique22
In situ breast cancer surgeries in Sweden: lumpectomy or mastectomy?—a cost-effectiveness analysis over a 30-Year period using Markov model21
Prescription cost analysis and economic impact of drug treatment in patients with chronic illness, attending the medicine out-patient department in a tertiary care hospital at South Delhi16
Quantifying the direct cost benefits of vestibular telemetry using the CAVA system to diagnose the causes of dizziness15
Willingness to pay for cataract surgery and its associated factors in selected medical centers in Urmia, Iran15
Cost-effectiveness analysis of coronary arteries bypass grafting (CABG) and percutaneous coronary intervention (PCI) through drug stent in iran: a comparative study15
Use of real-world evidence to support regulatory decisions on medical devices in China and a unique opportunity to gain accelerated approval in “Boao Lecheng Pilot Zone”15
Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening15
How a thrombectomy service can reduce hospital deficit: a cost-effectiveness study14
Economic burden of knee joint replacement in Iran14
Cost-effectiveness analysis of surgical proximal femur fracture prevention in elderly: a Markov cohort simulation model14
Understanding the impact of unequal utilization of medical services on the consumption of resources in hemophilia14
Cost-effectiveness of sacituzumab govitecan for hormone receptor-positive human epidermal growth factor receptor 2-negative metastatic breast cancer based on the EVER-132-002 trial in China13
Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study in 202113
A systemmatic literature review on indirect costs of women with breast cancer12
Hyperkalemia in chronic kidney disease patients with and without heart failure: an Italian economic modelling study12
A gender perspective of smoking cessation’s health and economic value in Jordanian women: using cost effectiveness model12
Cost-effectiveness analysis of isolation strategies for asymptomatic and mild symptom COVID-19 patients12
Disease-specific distress healthcare financing and catastrophic out-of-pocket expenditure for hospitalization care in Bangladesh11
Do Health Technology Assessment organisations consider manufacturers’ costs in relation to drug price? A study of reimbursement reports11
Cost-effectiveness of ceftolozane/tazobactam compared to meropenem in ventilator-associated pneumonia11
The effect of hospital budgeting system on physician-executives’ budget cognitive consciousness and medical decision making11
The importance and effectiveness of nutritional counselling in patients with autoimmune thyroid diseases in Poland11
Is Aducanumab treatment developed to prevent progression of Alzheimer's disease cost-effective in Turkey?10
Successes and challenges of China’s health care reform: a four-decade perspective spanning 1985—202310
Operationalizing game-theoretic weighting in public hospital cost control: an implementation framework from Chinese tertiary hospitals10
The cost of delivering COVID-19 vaccines in four districts in Malawi10
Assessing diagnosis-related groups based direct medical expenditures of chronic disease patients in general hospital of lower southern Thailand10
Cost-effectiveness of left atrial appendage closure for stroke prevention in atrial fibrillation: a systematic review appraising the methodological quality10
Expenditure and use on radiology imaging in urban and rural areas in a developing country10
Regional disparities, dynamic evolution, and spatial spillover effects of medical resource allocation efficiency in TCM hospitals10
The cost-effectiveness of standalone HEPA filtration units for the prevention of airborne SARS CoV-2 transmission9
A cost-effectiveness modeling study of treatment interventions for stage I to III esophageal squamous cell carcinoma9
Cost-effectiveness analysis of a new paradigm to simplify testing, monitoring and treatment of hepatitis C virus in the United States9
IAPN: a simple framework for evaluating whether a population-based risk stratification tool will be cost-effective before implementation9
Review for cost-effectiveness analysis of laparoscopic Intra-peritoneal Onlay Mesh for ventral hernia repair in Indian settings9
Systematic review of economic evaluations on stereotactic ablative radiotherapy (SABR) compared to other radiotherapy techniques or surgical procedures for early-stage non-small cell lung cancer9
Factors influencing the demand for individual voluntary private health insurance in Iran8
Analysis of costs in implementing the HEARTS hypertension program in Nigerian primary care8
Cost utility and budget impact analysis of dexamethasone compared with bortezomib and lenalidomide for the treatment of second line multiple myeloma from a South African public health perspective8
What are economic costs and when should they be used in health economic studies?8
The population-level economic burden of liver cancer in China, 2019–2030: prevalence-based estimations from a societal perspective8
A systematic review of the economic evaluations of Enzyme Replacement Therapy in Lysosomal Storage Diseases8
Economic evaluation of dialysis and comprehensive conservative care for chronic kidney disease using the ICECAP-O and EQ-5D-5L; a comparison of evaluation instruments8
Rapid cost-effectiveness analysis: hemodialysis versus peritoneal dialysis for patients with acute kidney injury in Rwanda8
The stochastic frontier analysis technique in measuring the technical and economic efficiency of hospital diagnostic laboratories: a case study in Iran8
A cost-benefit analysis of mass prostate cancer screening7
The influence of cross-regional medical treatment on total medical expenses, medical insurance payments, and out-of-pocket expenses of patients with malignant tumors in Chinese low-income areas7
Cost-effectiveness and budget impact analysis of Daratumumab, Lenalidomide and dexamethasone for relapsed-refractory multiple myeloma7
Cost-utility analysis of prenatal diagnosis of congenital cardiac diseases using deep learning7
Costs of fall injuries in the STRIDE study: an economic evaluation of healthcare system heterogeneity and heterogeneity of treatment effect7
Cost-effectiveness of proton beam therapy vs. conventional radiotherapy for patients with brain tumors in Sweden: results from a non-randomized prospective multicenter study7
Cost-effectiveness analysis of ceftazidime avibactam versus colistin in carbapenem-resistant enterobacteriaceae in Iran7
Selecting the most suitable organizational structure for hospitals: an integrated fuzzy FUCOM-MARCOS method7
Comparative Efficiency Analysis of OECD Health Systems: FDH vs. Machine Learning Approaches with Efficiency Analysis Trees (EAT and RFEAT)7
Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer7
From pilot to national roll-out of the improved Community Health Fund (iCHF) in Tanzania: lessons learnt and way forward7
Health economic analysis of third-line interventions in diffuse large B-cell lymphomas in Germany: applying the efficiency frontier7
Return on investment in science: twenty years of European Commission funded research in Alzheimer’s dementia, breast cancer and prostate cancer7
Cost-effectiveness analysis of COVID-19 tests in the unified health system7
The direct cost of chronic kidney disease (CKD) reported in Asian countries; a systematic literature review6
The FLURESP European commission project: cost-effectiveness assessment of ten public health measures against influenza in Italy: is there an interest in COVID-19 pandemic?6
Correction to: Medical expenses and its determinants in female patients with urological disorder6
A health economics assessment of self-care with over-the-counter ibuprofen in dysmenorrhoea, migraine and acute rhinosinusitis in the United Kingdom6
The role of routine chest radiography after implantable venous access port catheter insertion under the guide of ultrasonography and fluoroscopy6
Measuring efficiency of public hospitals under the impact of Covid-19: the case of Türkiye6
Economic burden of breast cancer: a case of Southern Iran6
Population ageing and sustainability of healthcare financing in China6
Loss ratio of the capitation payment unit of the health-promoting entities in Colombia between 2017 and 2021: a financial–actuarial approach6
Correction: One-stage vs two-stage bilateral THA in Lombardy: a cost-effectiveness analysis6
Comparing methods for handling missing cost and quality of life data in the Early Endovenous Ablation in Venous Ulceration trial6
Willingness to join community-based health insurance and associated factors among households in Ethiopian: a systematic review and meta-analysis6
Long-term cost-utility analysis of family therapy vs. treatment as usual for young people seen after self-harm5
Strategic analysis of financing communicable diseases in Afghanistan5
Cost-effectiveness of integrated disease management for high risk, exacerbation prone, patients with chronic obstructive pulmonary disease in a primary care setting5
A cost-utility analysis of Glecaprevir/Pibrentasvir versus Sofosbuvir/Daclatasvir and Sofosbuvir/Velpatasvir for treatment of hepatitis C in Iran5
Methodology and results of cost-effectiveness of LDL-C lowering with evolocumab in patients with acute myocardial infarction in China5
Impact of including productivity costs in economic analyses of vaccines for C. difficile infections and infant respiratory syncytial virus, in a UK setting5
Analysis of policy responses to COVID-19: a case study in Babol University of Medical Sciences (BUMS), Iran5
Estimating the cost-effectiveness threshold of advanced non-small cell lung cancer in China using mean opportunity cost and contingent valuation method5
Validation of the PECUNIA reference unit costs templates in Spain: a useful tool for multi-national economic evaluations of health technologies5
Out-of-pocket costs, time burden, and caregiver quality of life associated with pediatric medically attended respiratory syncytial virus illnesses5
Health economic evidence for adjuvant chemotherapy in stage II and III colon cancer: a systematic review5
The value of admission avoidance: cost-consequence analysis of one-year activity in a consolidated service5
Cost-effectiveness analysis of an implantable cardiac defibrillator compared with pharmaceutical therapy in patients hospitalized with arrhythmia in Iran5
HPV vaccination strategy for 14-year-old females and economic returns for cervical cancer prevention in Wuxi City, China: a cost effectiveness analysis5
Analysis on the individual and allocation efficiencies of health resources in China: 2008–20215
The role of economic evaluation in modelling public health and social measures for pandemic policy: a systematic review5
Impacts of the medical arms race on medical expenses: a public hospital-based study in Shenzhen, China, during 2009–20135
Cost-effectiveness of pharmacological therapies for people with Alzheimer’s disease and other dementias: a systematic review and meta-analysis5
Impact of a diabetes pay-for-performance program on nonincentivized mental disorders: a panel study based on claims database analysis5
Cost-effectiveness analysis of robot-assisted gait training in patients with bilateral spastic cerebral palsy5
The burden of health expenditure on household impoverishment in Ethiopia: a systematic review and meta-analysis5
Cost-effectiveness of COVID-19 vaccination in Latin America and the Caribbean: an analysis in Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, and Peru5
Medical expenses and its determinants in female patients with urological disorder5
Cost-effectiveness of RefluxStop compared to proton pump inhibitors and Nissen fundoplication for management of persistent gastroesophageal reflux disease in Norway5
Pharmacoeconomic evaluation of treatments for Poly Cystic Ovarian Syndrome (PCOS)5
0.5555260181427